Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, has named 20 world-class researchers from four countries as Citation Laureates™. These are researchers whose work is deemed to be ‘of Nobel class’, as demonstrated by analysis carried out by the Institute for Scientific Information (ISI)™, part of Clarivate.
The contributions of this year’s Citation Laureates include transformative research in breast and ovarian cancer, flexible ‘electronic skin’, the economics of happiness and well-being, and more. Fourteen of the honorees are based at leading academic institutions in the United States, three are based in Japan, two are based in the United Kingdom and one is based in Germany.
Each year since 2002, ISI analysts have drawn on Web of Science™ publication and citation data to identify influential researchers in the research areas recognized by Nobel Prizes: Physiology or Medicine, Physics, Chemistry, and Economics. Out of some 55 million articles and proceedings indexed in the Web of Science since 1970, only about 7,600 (.01%) have been cited 2,000 or more times. It is from the authors of this group of papers that Citation Laureates are identified and selected. They are individuals whose research publications are highly cited and whose contributions in their fields have been extremely influential, even transformative.
In early October 2022, the Nobel Assembly will vote to confer science’s highest honor. While this annual rite inspires worldwide speculation, Clarivate is the only organization to use quantitative data in addition to qualitative assessment to provide valuable insights about who might be chosen. To date, 64 Citation Laureates listed in the Hall of Citation Laureates have gone on to receive a Nobel Prize.
Click here to read the original press release.